Brentuximab vedotin administered concurrently with multi-agent chemotherapy as frontline treatment of ALCL and other CD3O-positive mature T-cell and NK-cell lymphomas Meeting Abstract
| Authors: | Fanale, M. A.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Midge, T.; Kennedy, D. A.; Horwitz, S. M. |
| Abstract Title: | Brentuximab vedotin administered concurrently with multi-agent chemotherapy as frontline treatment of ALCL and other CD3O-positive mature T-cell and NK-cell lymphomas |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000313838900104 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.60.60 |
| Notes: | --- - Meeting Abstract: 60 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
